Literature DB >> 29025991

Crystal structure of a TAPBPR-MHC I complex reveals the mechanism of peptide editing in antigen presentation.

Jiansheng Jiang1, Kannan Natarajan1, Lisa F Boyd1, Giora I Morozov1,2, Michael G Mage1, David H Margulies3.   

Abstract

Central to CD8+ T cell-mediated immunity is the recognition of peptide-major histocompatibility complex class I (p-MHC I) proteins displayed by antigen-presenting cells. Chaperone-mediated loading of high-affinity peptides onto MHC I is a key step in the MHC I antigen presentation pathway. However, the structure of MHC I with a chaperone that facilitates peptide loading has not been determined. We report the crystal structure of MHC I in complex with the peptide editor TAPBPR (TAP-binding protein-related), a tapasin homolog. TAPBPR remodels the peptide-binding groove of MHC I, resulting in the release of low-affinity peptide. Changes include groove relaxation, modifications of key binding pockets, and domain adjustments. This structure captures a peptide-receptive state of MHC I and provides insights into the mechanism of peptide editing by TAPBPR and, by analogy, tapasin.
Copyright © 2017, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29025991      PMCID: PMC6320693          DOI: 10.1126/science.aao5154

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  45 in total

1.  Utilizing TAPBPR to promote exogenous peptide loading onto cell surface MHC I molecules.

Authors:  F Tudor Ilca; Andreas Neerincx; Mark R Wills; Maike de la Roche; Louise H Boyle
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-13       Impact factor: 11.205

2.  Metal-triggered conformational reorientation of a self-peptide bound to a disease-associated HLA-B*27 subtype.

Authors:  Ronja Driller; Martin Ballaschk; Peter Schmieder; Barbara Uchanska-Ziegler; Andreas Ziegler; Bernhard Loll
Journal:  J Biol Chem       Date:  2019-07-11       Impact factor: 5.157

3.  Microfluidic on-demand engineering of exosomes towards cancer immunotherapy.

Authors:  Zheng Zhao; Jodi McGill; Pamela Gamero-Kubota; Mei He
Journal:  Lab Chip       Date:  2019-05-14       Impact factor: 6.799

4.  Production of soluble pMHC-I molecules in mammalian cells using the molecular chaperone TAPBPR.

Authors:  Sara M O'Rourke; Giora I Morozov; Jacob T Roberts; Adam W Barb; Nikolaos G Sgourakis
Journal:  Protein Eng Des Sel       Date:  2019-12-31       Impact factor: 1.650

Review 5.  A personal retrospective on the mechanisms of antigen processing.

Authors:  Peter Cresswell
Journal:  Immunogenetics       Date:  2019-01-29       Impact factor: 2.846

6.  Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity.

Authors:  Brogan Yarzabek; Anita J Zaitouna; Eli Olson; Gayathri N Silva; Jie Geng; Aviva Geretz; Rasmi Thomas; Sujatha Krishnakumar; Daniel S Ramon; Malini Raghavan
Journal:  Elife       Date:  2018-07-10       Impact factor: 8.140

Review 7.  Structural aspects of chaperone-mediated peptide loading in the MHC-I antigen presentation pathway.

Authors:  Kannan Natarajan; Jiansheng Jiang; David H Margulies
Journal:  Crit Rev Biochem Mol Biol       Date:  2019-05-14       Impact factor: 8.250

8.  Tumor-associated calreticulin variants functionally compromise the peptide loading complex and impair its recruitment of MHC-I.

Authors:  Najla Arshad; Peter Cresswell
Journal:  J Biol Chem       Date:  2018-05-16       Impact factor: 5.157

Review 9.  What to do with HLA-DO/H-2O two decades later?

Authors:  Robin Welsh; Nianbin Song; Scheherazade Sadegh-Nasseri
Journal:  Immunogenetics       Date:  2019-01-26       Impact factor: 2.846

10.  Atomistic structure and dynamics of the human MHC-I peptide-loading complex.

Authors:  Olivier Fisette; Gunnar F Schröder; Lars V Schäfer
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.